19 research outputs found

    Učinci probiotika koji sadrže Bacillus subtilis na crijevnu mikrofloru, kakvoću žutanjka i koncentracije lipida u krvi prepelica nesilica pasmine faraon

    Get PDF
    The current literature is not comprehensive concerning the influence of Bacillus subtilis on lipid metabolism, egg chemical characteristics, and intestinal microbiota of Japanese quail. The aim of this study was to evaluate the effects of a Bacillus subtilis strain on yolk quality, gut bacterial populations, and total cholesterol and triglyceride concentrations in the plasma of organically farmed Pharaon quail layers. Forty-five-day-old female quails were randomly distributed into four groups of 10 birds each: a no-treatment control group and three test groups receiving powder of Bacillus subtilis DSM 32424 at a minimum rate of 1 × 106 colony forming units per gram, dissolved in drinking water at doses of 50, 75 and 100 mg per kg body weight, daily during 30 days. The use of the probiotic at doses of 50 and 100 mg resulted in significantly reduced faecal staphylococci count on day 30 (P<0.05), while no significant changes were detected in lactobacilli or coliform bacteria. This study gives the first evidence of the influence of Bacillus subtilis on acid value and carotenoid levels in egg yolks laid by quails. Carotenoids were significantly elevated in the 75 mg group on day 30 (P<0.05), but significantly decreased in the 50 and 100 mg groups (P<0.05). Acidity, triglyceride and total cholesterol concentrations in quail serum were not affected significantly by the treatment throughout the study, though their values were reduced. The inclusion of Bacillus subtilis DSM 32424 in drinking water for laying Pharaon quails inhibited faecal staphylococci proliferation and enhanced yolk carotenoid content. Therefore, it can be proposed that including this probiotic in laying quail diets may have beneficial outcomes for both layers and the second generation.Ovaj rad nije sveobuhvatan obzirom na utjecaj Bacillus subtilis na metabolizam lipida, kemijska svojstva jaja te crijevne mikroorganizme japanskih prepelica. Istraživanje je obavljeno u svrhu procjene učinaka Bacillus subtilis soja na kakvoću žutanjka, populacije bakterija u crijevima uz ukupne koncentracije kolesterola i triglicerida u krvi organski uzgajanih prepelica nesilica pasmine faraon. Četrdesetpetodnevne ženke prepelice nasumice su podijeljene u četiri skupine od po 10 ptica: kontrolnu skupinu koja nije primala dodatak prehrani i tri pokusne skupine koje su primale prašak Bacillus subtilis DSM 32424 pri najmanjem postotku od 1 × 106 jedinica koje stvaraju koloniju po gramu, otopljen u pitkoj vodi u dozama od 50, 75 i 100 mg po kilogramu tjelesne težine, svakodnevno tijekom 30 dana. Uporaba probiotika u dozama od 50 i 100 mg rezultirala je značajnim smanjenjem količine fekalnih stafilokoka na 30. dan (P<0,05), dok značajnije promjene laktobacila i koliformnih bakterija nisu otkrivene. Ovo je istraživanje prvi put pokazalo utjecaj Bacillus subtilis na vrijednost kiseline i razine karotenoida u žutanjcima koje nesu prepelice. Karotenoidi su se značajno podigli na 30. dan u skupini koja je primala 75 mg (P<0,05), ali su se i značajno smanjili u skupinama koje su primale 50 i 100 mg (P<0,05). Terapija nije statistički značajno djelovala na kiselinu. Pokusni dodatak nije značajno utjecao niti na koncentracije triglicerida i ukupni kolesterol u krvi prepelica tijekom ispitivanja, premda su te koncentracije dosta smanjene. Na temelju dobivenih rezultata, zaključeno je da je dodavanje Bacillus subtilis DSM 32424 u pitku vodu za prepelice nesilice pasmine Faraon gotovo na svim proučavanim razinama inhibiralo proliferaciju fekalnih stafilokoka i povećalo udio karotenoida u žutanjku. Stoga se može reći da uključivanje probiotika u prehranu prepelica nesilica može imati korisni učinak i na nesilice i na drugu generaciju

    Cross-sectional study on the characteristics of unrecorded alcohol consumption in nine newly independent states between 2013 and 2017

    Get PDF
    Objectives: As unrecorded alcohol use contributes to a substantial burden of disease, this study characterises this phenomenon in newly independent states (NIS) of the former Soviet Union with regard to the sources of unrecorded alcohol, and the proportion of unrecorded of total alcohol consumption. We also investigate associated sociodemographic characteristics and drinking patterns. Design: Cross-sectional data on overall and unrecorded alcohol use in the past 7 days from WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) surveys. Descriptive statistics were calculated at the country level, hierarchical logistic and linear regression models were used to investigate sociodemographic characteristics and drinking patterns associated with using unrecorded alcohol. Setting: Nine NIS (Armenia, Azerbaijan, Belarus, Georgia, Kyrgyzstan, Republic of Moldova, Tajikistan, Turkmenistan and Uzbekistan) in the years 2013–2017. Participants: Nationally representative samples including a total of 36 259 participants. Results: A total of 6251 participants (19.7%; 95% CI 7.9% to 31.5%) reported alcohol consumption in the past 7 days, 2185 of which (35.1%; 95% CI 8.2% to 62.0%) reported unrecorded alcohol consumption with pronounced differences between countries. The population-weighted average proportion of unrecorded consumption in nine NIS was 8.7% (95% CI 5.9% to 12.4%). The most common type of unrecorded alcohol was home-made spirits, followed by home-made beer and wine. Older (45–69 vs 25–44 years) and unemployed (vs employed) participants had higher odds of using unrecorded alcohol. More nuanced sociodemographic differences were observed for specific types of unrecorded alcohol. Conclusions This contribution is the first to highlight both, prevalence and composition of unrecorded alcohol consumption in nine NIS. The observed proportions and sources of unrecorded alcohol are discussed in light of local challenges in policy implementation, especially in regard to the newly formed Eurasian Economic Union (EAEU), as some but not all NIS are in the EAEU

    ПРИМЕНЕНИЕ ИПИЛИМУМАБА У БОЛЬНЫХ ДИССЕМИНИРОВАННОЙ МЕЛАНОМОЙ КОЖИ

    Get PDF
    Introduction: Application of ipilimumab (IPI) in the treatment of patients with disseminated melanoma, first demonstrated an increase in survival that was an important event in cancer immunotherapy. We present the results of treatment of patients within the framework of enhanced access to the drug (SA184-EAP).Materials and methods: from September 2012 to August 2014 71 patients with metastatic melanoma, with signs of tumor progression, received earlier from 1 to 6 lines of drug therapy were enrolled in protocol of treatment in Petrov Oncology Institute. Median age of patients was 51 years (range from 21 to 76 years). In 39 (60%) of patients IV stage was diagnosed, 25% of patients had metastases to the brain, 28% - had liver metastases, 19% - had bone metastases. All patients received IPI 3 mg/kg once every 3 weeks for total 4 administration.Results: A total there were 229 administrations of IPI in 71 patients (average number of administrations was 3.2). Thirty-nine patients (59%) had 4 administrations and 21 patients (35%) had 1-2 administrations. Most of the patients had at least one adverse event (AE) associated with the treatment. In 15 patients (21%) there were no adverse events. Three patients died due to adverse events possibly related to treatment: 1 – had kidney failure, 1 - had pulmonary embolism, 1 - had cerebral edema and the progression of cancer. Grade 3-4 adverse events were observed in 10 (14.1%) patients: grade 3 rash  - in 3 (4.2%) patients, grade 3 diarrhea - in 2 (2.8%) patients, grade 3 fatigue - in 2 (2 8%) patients, grade 3 dyspnea - in 1 (1.4%) patients, grade 4 of ALT and AST increasing - in 1 (1.4%) patient, grade 3 hypokalemia - in 1 (1.5%) patient. Efficacy of treatment was assessed in 54 patients, complete regression was detected in 3 (6%) patients, partial - in 6 (11%) patients. An objective response to treatment was observed in 28% of patients, the stabilization of process in 6 (11%) patients. Median follow-up was 144 days. The median time to progression was 81 days (95%; CI 73-105). The median overall survival was 411 days (95%; CI - 303-519).Conclusion: Treatment with IPI satisfactorily tolerated by most patients and has significant clinical efficacy as the second and subsequent lines of drug therapy in patients with disseminated melanoma.Введение: Применение ипилимумаба (ИПИ) для лечения больных диссеминированной  меланомой  кожи, впервые продемонстрировавшее увеличение выживаемости, явилось важным событием в иммунотерапии  злокачественных опухолей. Мы представляем  результаты лечения больных в рамках программы  расширенного  доступа к препарату (СА184-ЕАР).Материалы и методы: В ФГБУ «НИИ онкологии  им.  Н. Н. Петрова» Минздрава России в программу с сентября2012 г. по август2014 г. включен 71 больной диссеминированной меланомой, с признаками прогрессирования опухолевого процесса, получивших ранее  от 1 до 6 линий лекарственной терапии. Средний возраст составил 51 год (21–76 лет). У 39 (60%) больных установлена IV стадия M1c, 25% пациентов имели метастатическое поражение головного мозга, 28% – метастазы в печени, 19% – метастазы в костях. Все больные получали ИПИ в дозе 3 мг/кг 1 раз в 3 недели, всего 4 введения.Результаты: У  71 больного проведено 229 введений  ИПИ (в среднем-3,2).  Тридцать девять больных (59%) получили 4 введений, 21 (35%) – 1–2 введения.  Большинство пациентов имело хотя бы одно нежелательное явление (НЯ), связанное  с лечением. У  15 больных (21%) нежелательных явлений не наблюдалось. Трое больных умерло от нежелательных явлений, возможно связанных с проводимой терапией: 1 – от почечной недостаточности, 1 – от тромбоэмболии легочной артерии, 1 – от отека головного мозга на фоне прогрессирования  опухолевого процесса. НЯ 3–4 ст. наблюдались  у 10 (14,1%) больных: сыпь 3 ст.– у 3 (4,2%), диарея 3 ст. у 2 (2,8%), слабость 3 ст. у 2 (2,8%), одышка 3 ст. у 1 (1,4%), повышение уровня АЛТ и АСТ 4 ст. у 1 (1,4%), гипокалиемия 3 ст. у 1 (1,5%) больных. Эффективность лечения оценена у 54 больных, полный регресс  выявлен у 3 (6%) больных, частичный – у 6 (11%) больных. Объективный ответ на терапию наблюдался  у 28% пацинентов, стабилизация  процесса  у 6 (11%). Средняя длительность наблюдения составила 144 дня. Медиана времени до прогрессирования – 81 (95% ДИ 73–105)  дней. Медиана общей выживаемости составила 411 дней (95% ДИ – 303–519).Заключение: Терапия  ИПИ удовлетворительно переносится большинством больных и обладает значимой клинической эффективностью в качестве второй и последующих линий лекарственной  терапии у пациентов диссеминированной  меланомой  кожи

    Exploring educational inequalities in hypertension control, salt knowledge and awareness, and patient advice : insights from the WHO STEPS surveys of adults from nine Eastern European and Central Asian countries

    Get PDF
    Objective: To inform strategies aimed at improving blood pressure (BP) control and reducing salt intake, we assessed educational inequalities in high blood pressure (HBP) awareness, treatment and control; physician’s advice on salt reduction; and salt knowledge, perceptions and consumption behaviours in Eastern Europe and Central Asia. Design: Data were collected in cross-sectional, population-based nationally representative surveys, using a multi-stage clustered sampling design. Five HBP awareness, treatment and control categories were created from measured BP and hypertension medication use. Education and other variables were self-reported. Weighted multinomial mixed-effects regression models, adjusted for confounders, were used to assess differences across education categories. Settings: Nine Eastern European and Central Asian countries (Armenia, Azerbaijan, Belarus, Georgia, Kyrgyzstan, Republic of Moldova, Tajikistan, Turkey and Uzbekistan). Participants: Nationally representative samples of 30 455 adults aged 25–65 years. Results: HBP awareness, treatment and control varied substantially by education. The coverage of physician’s advice on salt was less frequent among participants with lower education, and those with untreated HBP or unaware of their HBP. The education gradient was evident in salt knowledge and perceptions of salt intake but not in salt consumption behaviours. Improved salt knowledge and perceptions were more prevalent among participants who received physician’s advice on salt reduction. Conclusions: There is a strong education gradient in HBP awareness, treatment and control as well as salt knowledge and perceived intake. Enhancements in public and patient knowledge and awareness of HBP and its risk factors targeting socio-economically disadvantaged groups are urgently needed to alleviate the growing HBP burden in low- and middle-income countries

    Belarus: health system review.

    Get PDF
    This analysis of the Belarusian health system reviews the developments in organization and governance, health financing, healthcare provision, health reforms and health system performance since 2008. Despite considerable change since independence, Belarus retains a commitment to the principle of universal access to health care, provided free at the point of use through predominantly state-owned facilities, organized hierarchically on a territorial basis. Incremental change, rather than radical reform, has also been the hallmark of health-care policy, although capitation funding has been introduced in some areas and there have been consistent efforts to strengthen the role of primary care. Issues of high costs in the hospital sector and of weaknesses in public health demonstrate the necessity of moving forward with the reform programme. The focus for future reform is on strengthening preventive services and improving the quality and efficiency of specialist services. The key challenges in achieving this involve reducing excess hospital capacity, strengthening health-care management, use of evidence-based treatment and diagnostic procedures, and the development of more efficient financing mechanisms. Involving all stakeholders in the development of further reform planning and achieving consensus among them will be key to its success

    Application of Siliplant in the technology of growing potato minitubers in protected soil conditions

    No full text
    Under greenhouse conditions the effect of silicon-containing preparation with complex action, capable of simultaneously stimulating plant ontogenesis, photosynthetic processes and increasing the productivity and quality of plants was studied. The purpose of this study was to study the effect of the silicon-containing preparation Siliplant on the productivity and quality of minitubers of early maturity potato varieties Vineta in the system of virus-free (original) potato seed production. Results demonstrated that Siliplant causes an increase in biometric and physiological parameters such as plant height (by 5.7%), the number of stems in the bush (by 30%), weight of roots (by 16.7%), leaf area (by 23.7%), net photosynthetic productivity (by 37%) compared with the control variant.Root treatments with the preparation increased the yield by 19.3 % and the multiplication factor by 20.0 % compared to the control. Also, the use of Siliplant contributed to a slight increase in quality indicators (17.7 - 2.5 %), respectively, compared to the control. Thus, the use of Siliplant in the double root treatment of potato microplants in protected soil conditions is a promising agricultural technique in the conditions of Nizhny Novgorod region, allowing to increase the productivity of photosynthesis, yields and its quality

    Cross-sectional study on the characteristics of unrecorded alcohol consumption in nine newly independent states between 2013 and 2017

    No full text
    Objectives: As unrecorded alcohol use contributes to a substantial burden of disease, this study characterises this phenomenon in newly independent states (NIS) of the former Soviet Union with regard to the sources of unrecorded alcohol, and the proportion of unrecorded of total alcohol consumption. We also investigate associated sociodemographic characteristics and drinking patterns. Design: Cross-sectional data on overall and unrecorded alcohol use in the past 7 days from WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) surveys. Descriptive statistics were calculated at the country level, hierarchical logistic and linear regression models were used to investigate sociodemographic characteristics and drinking patterns associated with using unrecorded alcohol. Setting: Nine NIS (Armenia, Azerbaijan, Belarus, Georgia, Kyrgyzstan, Republic of Moldova, Tajikistan, Turkmenistan and Uzbekistan) in the years 2013–2017. Participants: Nationally representative samples including a total of 36 259 participants. Results: A total of 6251 participants (19.7%; 95% CI 7.9% to 31.5%) reported alcohol consumption in the past 7 days, 2185 of which (35.1%; 95% CI 8.2% to 62.0%) reported unrecorded alcohol consumption with pronounced differences between countries. The population-weighted average proportion of unrecorded consumption in nine NIS was 8.7% (95% CI 5.9% to 12.4%). The most common type of unrecorded alcohol was home-made spirits, followed by home-made beer and wine. Older (45–69 vs 25–44 years) and unemployed (vs employed) participants had higher odds of using unrecorded alcohol. More nuanced sociodemographic differences were observed for specific types of unrecorded alcohol. Conclusions This contribution is the first to highlight both, prevalence and composition of unrecorded alcohol consumption in nine NIS. The observed proportions and sources of unrecorded alcohol are discussed in light of local challenges in policy implementation, especially in regard to the newly formed Eurasian Economic Union (EAEU), as some but not all NIS are in the EAEU

    Cross-sectional study on the characteristics of unrecorded alcohol consumption in nine newly independent states between 2013 and 2017

    Get PDF
    Objectives: As unrecorded alcohol use contributes to a substantial burden of disease, this study characterises this phenomenon in newly independent states (NIS) of the former Soviet Union with regard to the sources of unrecorded alcohol, and the proportion of unrecorded of total alcohol consumption. We also investigate associated sociodemographic characteristics and drinking patterns. Design: Cross-sectional data on overall and unrecorded alcohol use in the past 7 days from WHO STEPwise Approach to NCD Risk Factor Surveillance (STEPS) surveys. Descriptive statistics were calculated at the country level, hierarchical logistic and linear regression models were used to investigate sociodemographic characteristics and drinking patterns associated with using unrecorded alcohol. Setting: Nine NIS (Armenia, Azerbaijan, Belarus, Georgia, Kyrgyzstan, Republic of Moldova, Tajikistan, Turkmenistan and Uzbekistan) in the years 2013–2017. Participants: Nationally representative samples including a total of 36 259 participants. Results: A total of 6251 participants (19.7%; 95% CI 7.9% to 31.5%) reported alcohol consumption in the past 7 days, 2185 of which (35.1%; 95% CI 8.2% to 62.0%) reported unrecorded alcohol consumption with pronounced differences between countries. The population-weighted average proportion of unrecorded consumption in nine NIS was 8.7% (95% CI 5.9% to 12.4%). The most common type of unrecorded alcohol was home-made spirits, followed by home-made beer and wine. Older (45–69 vs 25–44 years) and unemployed (vs employed) participants had higher odds of using unrecorded alcohol. More nuanced sociodemographic differences were observed for specific types of unrecorded alcohol. Conclusions This contribution is the first to highlight both, prevalence and composition of unrecorded alcohol consumption in nine NIS. The observed proportions and sources of unrecorded alcohol are discussed in light of local challenges in policy implementation, especially in regard to the newly formed Eurasian Economic Union (EAEU), as some but not all NIS are in the EAEU
    corecore